United States Patent and Trademark Office

MALVERN, PA — Maxona Pharmaceuticals has announced the issuance of Patent No. 12,226,421 by the United States Patent and Trademark Office (USPTO) for MAX-001, the company’s breakthrough non-opioid, non-NSAID oral therapy …